[
  {
    "ts": null,
    "headline": "Becton Dickinson & Co. stock outperforms competitors despite losses on the day",
    "summary": "Becton Dickinson & Co. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=2dffc4a9b5f46771426997cd0b5a18ec93cd3ffb0c84805b3e38aa7523a1e417",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747846200,
      "headline": "Becton Dickinson & Co. stock outperforms competitors despite losses on the day",
      "id": 134640719,
      "image": "",
      "related": "BDX",
      "source": "MarketWatch",
      "summary": "Becton Dickinson & Co. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=2dffc4a9b5f46771426997cd0b5a18ec93cd3ffb0c84805b3e38aa7523a1e417"
    }
  },
  {
    "ts": null,
    "headline": "Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs'",
    "summary": "First-of-their-kind studies published in The Lancet Oncology1 and Cancer Medicine2 provide new data showing that cancer patients in both hospital and outpatient settings are at a substantially higher risk of developing antimicrobial resistant (AMR) infections compared to all other non-cancer patients.",
    "url": "https://finnhub.io/api/news?id=12307f625913acf4da9f7b4230fd015219a982b34c89c807569d26c57b558ef1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747823880,
      "headline": "Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs'",
      "id": 134628840,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "First-of-their-kind studies published in The Lancet Oncology1 and Cancer Medicine2 provide new data showing that cancer patients in both hospital and outpatient settings are at a substantially higher risk of developing antimicrobial resistant (AMR) infections compared to all other non-cancer patients.",
      "url": "https://finnhub.io/api/news?id=12307f625913acf4da9f7b4230fd015219a982b34c89c807569d26c57b558ef1"
    }
  },
  {
    "ts": null,
    "headline": "Becton, Dickinson and Company Announces Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs'",
    "summary": "Becton, Dickinson and Company provided new data showing that cancer patients in both hospital and outpatient settings are at a substantially higher risk of developing antimicrobial resistant ...",
    "url": "https://finnhub.io/api/news?id=b590e8d1d18b8a5d03eaa4a9e0e6829342a35f9a68f0a5c2af8813c8d9afd116",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747812939,
      "headline": "Becton, Dickinson and Company Announces Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs'",
      "id": 134624380,
      "image": "",
      "related": "BDX",
      "source": "Finnhub",
      "summary": "Becton, Dickinson and Company provided new data showing that cancer patients in both hospital and outpatient settings are at a substantially higher risk of developing antimicrobial resistant ...",
      "url": "https://finnhub.io/api/news?id=b590e8d1d18b8a5d03eaa4a9e0e6829342a35f9a68f0a5c2af8813c8d9afd116"
    }
  },
  {
    "ts": null,
    "headline": "Best Dividend Kings - May 2025",
    "summary": "Dividend Kings have outperformed the S&P 500 year-to-date, but recent momentum has slowed. Discover the full story here.",
    "url": "https://finnhub.io/api/news?id=783cf3a9b25bba76f793a8bcb80d813359f7ffa3eae279f58b34b03c0b343593",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747792261,
      "headline": "Best Dividend Kings - May 2025",
      "id": 134622076,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2166444456/image_2166444456.jpg?io=getty-c-w1536",
      "related": "BDX",
      "source": "SeekingAlpha",
      "summary": "Dividend Kings have outperformed the S&P 500 year-to-date, but recent momentum has slowed. Discover the full story here.",
      "url": "https://finnhub.io/api/news?id=783cf3a9b25bba76f793a8bcb80d813359f7ffa3eae279f58b34b03c0b343593"
    }
  }
]